• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012463-23
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hematoma (1884)
Event Date 10/27/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).The absorb 3.5 x 28 mm scaffold referenced is being filed under a separate manufacturer report number.The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the u.S.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.
 
Event Description
It was reported that the procedure was to treat a lesion located in the proximal, mid and distal left anterior descending (lad) artery with heavy calcification.Predilatation was performed and a 2.5x28mm absorb was placed in the distal lad.The placement was successful and uneventful.Then a 3.0x23mm absorb was placed in the mid lad.The placement was successful and uneventful.A 3.5x28mm absorb was advanced to the proximal lad and was placed overlapping the 3.0x23mm absorb with 9 atmospheres, one inflation for 30 seconds.While overlapping there was a hematoma that was seen in the overlapping area.A 3.0x28 xience alpine was then placed in the overlapping area successfully.There was no clinically significant delay in the procedure.The patient was doing fine and was later discharged.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6130335
MDR Text Key60990630
Report Number2024168-2016-08377
Device Sequence Number1
Product Code PNY
UDI-Device Identifier08717648157035
UDI-Public(01)08717648157035(17)170418(10)604196A
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 11/28/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/28/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/18/2017
Device Catalogue Number1012463-23
Device Lot Number604196A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/10/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SCAFFOLD: ABSORB (3.5 X 28, 2.5 X 28)
Patient Outcome(s) Required Intervention;
Patient Age44 YR
Patient Weight78
-
-